Over the period of their SBIR involvement, Pharmavene, Inc., was a pharmaceutical company using advanced drug delivery technologies to develop improved formulations of drugs (e.g., Carbatrol). In 1996 Pharmavene, Inc. was merged with Shire Pharmaceuticals, to become Shire Laboratories, Inc. where the company developed Adderall XR.